Ellex Medical Lasers Limited (Ellex) is a medical technology company. It develops, manufactures, services, and distributes a comprehensive range of medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes laser therapy equipment, surgical techniques, intraocular lenses (IOLs), photocoagulators, and ultrasound systems for the diagnosis and treatment of cataract, glaucoma and retinal diseases. It also offers retinal rejuvenation therapy, Ellex 2RT for the treatment of diabetic retinopathy and age-related macular degeneration (AMD). The company markets its products and services through subsidiaries in the US, Europe, Asia, Australia, and through a network of distribution partners the world over. Ellex is headquartered in Adelaide, Australia.
Ellex Medical Lasers Limited Key Recent Developments
Jun 15, 2016: Ellex Secures China FDA Approval for Ophthalmic Treatment Lasers
Jan 29, 2016: Trading Update for the Half-Year Ended 31 December 2015
Jan 22, 2016: Ellex expands production facilities to meet anticipated demand
Jul 30, 2015: Trading Update for the Full Year Ended 30 June 2015 - Ellex Medical Lasers Limited
Mar 30, 2015: Ellex attending major tradeshow in China
Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.